Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

CUSIP: 81728J109

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+938,643
Put/Call ratio
28%
SEC-reported price per share
$7.22
Number of holders
37
Value change
+$8,095,278
Number of buys
29
Open additional details 1 more signal available
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,385,263

Security key

81728J109

Report period

Q4 2021

Institutions

37

Top holders

10

Ownership snapshot

Top reported holders of SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Stephen Brad Cohen
Disclosed value leader
Stephen Brad Cohen
Comparable rows
0/15
Latest evidence
15 Dec 2021
3/4/5 13F Highest disclosed value: $2,209,356 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Stephen Brad Cohen has the largest disclosed position value at $2.21M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Stephen Brad Cohen's linked filing trail.
Disclosed position value Top 5
Stephen Brad Cohen $2.21M
VANGUARD GROUP INC $1.73M
Invenomic Capital Management LP $985K
BlackRock Finance, Inc. $441K
Financial Engines Advisors L.L.C. $295K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Stephen Brad Cohen
3/4/5
EXECUTIVE VICE PRESIDENT
—
denominator unverified
$2,209,356
830,585 shares
— 15 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,730,000
480,523 shares
— 30 Sep 2021
Invenomic Capital Management LP
13F
Company
13F
—
denominator unverified
$985,000
273,342 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$441,000
122,514 shares
— 30 Sep 2021
Financial Engines Advisors L.L.C.
13F
Company
13F
—
denominator unverified
$295,000
82,194 shares
— 30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$249,000
69,332 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
37
Shares
2,277,916
Rows available
37
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
18
Q4 2021 holders
37
Holder diff
19
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .